Torrent Pharmaceuticals is strengthening its chronic care and specialty medicine business as healthcare demand continues growing in both domestic and international markets. The company is focusing on cardiovascular, diabetes, and neurological treatment segments.
Increasing healthcare awareness and rising demand for affordable medicines are supporting long-term growth opportunities in the pharmaceutical industry. Torrent Pharma is also investing in research, product approvals, and export expansion.
Analysts believe the company’s diversified product mix and stable domestic presence could support consistent business growth over the coming years.
